Skip to main content
Top
Published in: Intensive Care Medicine 5/2003

01-05-2003 | Original

RETRACTED ARTICLE: Influence of two different volume replacement regimens on renal function in elderly patients undergoing cardiac surgery: comparison of a new starch preparation with gelatin

Authors: Joachim Boldt, Thorsten Brenner, Andreas Lehmann, Johannes Lang, Bernhard Kumle, Christiane Werling

Published in: Intensive Care Medicine | Issue 5/2003

Login to get access

Abstract

Objective

There is continuing concern on the influence of hydroxethyl starch (HES) on renal function.

Design

Prospective, randomized study.

Setting

University-affiliated medical center.

Patients

Forty consecutive patients aged >70 years undergoing cardiac surgery using cardiopulmonary bypass.

Interventions

Either low-molecular HES (mean molecular weight: 130 kD) with low degree of substitution (0.4) (6% HES 130/0.4) (n=20) or gelatin (n=20) was given after induction of anesthesia until the 2nd postoperative day (POD) to keep central venous pressure between 12–14 mmHg.

Measurements and results

Creatinine clearance (CC) and fractional sodium clearance (FSC) were measured. N-acetyl-beta-D-glucosamidase , alpha-1-microglobulin , glutathione transferase-pi , and glutathione transferase-alpha were measured from urine specimens. Measurements were made after induction of anesthesia, at the end of surgery, and at the first and the second POD. More gelatin (total: 4150±490 ml) than HES 130/0.4 (total: 3450±450 ml) was infused within the study. CC and FSC were without differences between the two groups. All measured kidney-specific proteins were almost within normal range at baseline. They increased significantly after surgery, however, without significant group differences. At the 2nd POD, kidney-specific proteins had returned almost to normal values. None of the patients developed acute renal failure.

Conclusions

Sensitive markers of kidney dysfunction increased in our elderly patients indicating moderate alterations in kidney integrity during cardiac surgery. The two volume replacement regimens did not differ with regard to kidney integrity in elderly patients undergoing cardiac surgery.
Literature
1.
go back to reference Marik PE, Iglesias J, Marini B (1997) Gastric intramucosal pH changes after volume replacement with hydroxyethyl starch or crystalloid in patients undergoing elective abdominal aortic aneurysm repair. J Crit Care 12:51–55CrossRef Marik PE, Iglesias J, Marini B (1997) Gastric intramucosal pH changes after volume replacement with hydroxyethyl starch or crystalloid in patients undergoing elective abdominal aortic aneurysm repair. J Crit Care 12:51–55CrossRef
2.
go back to reference Mythen MG, Webb AR (1994) The role of gut mucosal hypoperfusion in the pathogenesis of postoperative organ dysfunction. Intensive Care Med 20:203–209CrossRef Mythen MG, Webb AR (1994) The role of gut mucosal hypoperfusion in the pathogenesis of postoperative organ dysfunction. Intensive Care Med 20:203–209CrossRef
3.
go back to reference Warren BB, Durieux ME (1997) Hydroxyethylstarch: safe or not? Anesth Analg 84:206–212CrossRef Warren BB, Durieux ME (1997) Hydroxyethylstarch: safe or not? Anesth Analg 84:206–212CrossRef
4.
go back to reference Traylor RJ, Pearl R (1996) Crystalloid versus colloid: all colloids are not created equal. Anesth Analg 83:209–212CrossRef Traylor RJ, Pearl R (1996) Crystalloid versus colloid: all colloids are not created equal. Anesth Analg 83:209–212CrossRef
5.
go back to reference Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou C, Coriat P (1996) Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 348:1620–1622CrossRef Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou C, Coriat P (1996) Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 348:1620–1622CrossRef
6.
go back to reference Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, Brochard L (2001) Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicenter randomised study. Lancet 357:911–916CrossRef Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, Brochard L (2001) Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicenter randomised study. Lancet 357:911–916CrossRef
7.
go back to reference Peron S, Mouthon L, Guettier C, Brechignac S, Cohen P, Guillevin L (2001) Hydroxyethyl starch-induced renal insufficiency after plasma exchange in a patient with polymyositis and liver cirrhosis. Clin Nephrol 55:408–411PubMed Peron S, Mouthon L, Guettier C, Brechignac S, Cohen P, Guillevin L (2001) Hydroxyethyl starch-induced renal insufficiency after plasma exchange in a patient with polymyositis and liver cirrhosis. Clin Nephrol 55:408–411PubMed
8.
go back to reference De Labarthe A, Jacobs F, Blot F, Glotz D (2001) Acute renal failure secondary to hydroxyethylstarch administration in a surgical patient. Am J Med 111:417–418CrossRef De Labarthe A, Jacobs F, Blot F, Glotz D (2001) Acute renal failure secondary to hydroxyethylstarch administration in a surgical patient. Am J Med 111:417–418CrossRef
9.
go back to reference Ducke G, Briedis JH, Weaver RA (1994) Renal support in critically ill patients: low dose dopamine or low dose-dobutamine? Crit Care Med 22:1919–1925CrossRef Ducke G, Briedis JH, Weaver RA (1994) Renal support in critically ill patients: low dose dopamine or low dose-dobutamine? Crit Care Med 22:1919–1925CrossRef
10.
go back to reference Morgera S, Woydt R, Kern H, Schmutzler M, DeJonge K, Lun A, Rohde W, Konertz W, Kow WJ, Neumayer HM (2002) Low-dose prostacyclin preserves renal function in high-risk patients after coronary bypass surgery. Crit Care Med 30:107–112CrossRef Morgera S, Woydt R, Kern H, Schmutzler M, DeJonge K, Lun A, Rohde W, Konertz W, Kow WJ, Neumayer HM (2002) Low-dose prostacyclin preserves renal function in high-risk patients after coronary bypass surgery. Crit Care Med 30:107–112CrossRef
11.
go back to reference Chew STH, Newman MF, White WD, Conlon PJ, Saunders AM, Strittmatter WJ, Landolfo K, Grocott HP, Stafford-Smith M (2000) Prelimary report on the association of apolipoprotein E polymorphisms, with postoperative peak serum creatinine concentrations in cardiac surgical patients. Anesthesiology 93:325–331CrossRef Chew STH, Newman MF, White WD, Conlon PJ, Saunders AM, Strittmatter WJ, Landolfo K, Grocott HP, Stafford-Smith M (2000) Prelimary report on the association of apolipoprotein E polymorphisms, with postoperative peak serum creatinine concentrations in cardiac surgical patients. Anesthesiology 93:325–331CrossRef
12.
go back to reference Kulka PJ, Tryba M, Zenz M (1996) Preoperative alpha-2-adrenergic receptor agonists prevent the deterioration of renal function after cardiac surgery: results of a randomized, controlled trial. Crit Care Med 24:947–952CrossRef Kulka PJ, Tryba M, Zenz M (1996) Preoperative alpha-2-adrenergic receptor agonists prevent the deterioration of renal function after cardiac surgery: results of a randomized, controlled trial. Crit Care Med 24:947–952CrossRef
13.
go back to reference Mangos GJ, Brown MA, Chan WY, Horton D, Trew P, Whitworth JA (1995) Acute renal failure following cardiac surgery: incidence, outcomes and risk factors. Aust N Z J Med 25:284–289CrossRef Mangos GJ, Brown MA, Chan WY, Horton D, Trew P, Whitworth JA (1995) Acute renal failure following cardiac surgery: incidence, outcomes and risk factors. Aust N Z J Med 25:284–289CrossRef
14.
go back to reference Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT (1998) Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 128:194–203CrossRef Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT (1998) Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 128:194–203CrossRef
15.
go back to reference Chertow GM, Lazerus JM, Christiansen CL, Cook EF, Hammermeister KE, Grover F, Daley J (1997) Preoperative renal risk stratification. Circulation 95:878–884CrossRef Chertow GM, Lazerus JM, Christiansen CL, Cook EF, Hammermeister KE, Grover F, Daley J (1997) Preoperative renal risk stratification. Circulation 95:878–884CrossRef
16.
go back to reference Lindeman RD (1992) Changes in renal function with aging: implications for treatment. Drugs Aging 2:423–431CrossRef Lindeman RD (1992) Changes in renal function with aging: implications for treatment. Drugs Aging 2:423–431CrossRef
17.
go back to reference Jorres A, Kordonouri O, Schiessler A, Hess S, Farke S, Gahl GM, Muller C, Djurup R (1994) Urinary excretion of thromboxane and markers for renal injury in patients undergoing cardiopulmonary bypass. Artif Organs 18:565–569CrossRef Jorres A, Kordonouri O, Schiessler A, Hess S, Farke S, Gahl GM, Muller C, Djurup R (1994) Urinary excretion of thromboxane and markers for renal injury in patients undergoing cardiopulmonary bypass. Artif Organs 18:565–569CrossRef
18.
go back to reference Westhuyzen J, McGiffin DC, McCarthy J, Fleming SJ (1994) Tubular nephrotoxicity after cardiac surgery utilising cardiopulmonary bypass. Clin Chim Acta 228:123–132CrossRef Westhuyzen J, McGiffin DC, McCarthy J, Fleming SJ (1994) Tubular nephrotoxicity after cardiac surgery utilising cardiopulmonary bypass. Clin Chim Acta 228:123–132CrossRef
19.
go back to reference Costa P, Ottino GM, Matani A, Pansini S, Canavese C, Passerini G, Grezzana G (1990) Low-dose dopamine during cardiopulmonary bypass in patients with renal dysfunction. J Cardithorac Anesth 4:469–473CrossRef Costa P, Ottino GM, Matani A, Pansini S, Canavese C, Passerini G, Grezzana G (1990) Low-dose dopamine during cardiopulmonary bypass in patients with renal dysfunction. J Cardithorac Anesth 4:469–473CrossRef
20.
go back to reference Mantur M, Kemona H, Dabrowsky M, Dabrowska J, Sobolewski S, Prokopowicz J (2000) Alpha1-microglobulin as a marker of proximal tubular damage in urinary tract infection in children. Clin Nephrol 53:283–287PubMed Mantur M, Kemona H, Dabrowsky M, Dabrowska J, Sobolewski S, Prokopowicz J (2000) Alpha1-microglobulin as a marker of proximal tubular damage in urinary tract infection in children. Clin Nephrol 53:283–287PubMed
21.
go back to reference Sundberg AGM, Appelkvist EL, Bäckman L, Dallner G (1994) Quantitation of glutathione transferase-Pi in the urine by radioimmunaoassay. Nephron 66:162–169CrossRef Sundberg AGM, Appelkvist EL, Bäckman L, Dallner G (1994) Quantitation of glutathione transferase-Pi in the urine by radioimmunaoassay. Nephron 66:162–169CrossRef
22.
go back to reference Branten AJ, Mulder TP, Peters WH, Assmann KJ, Wetzels JF (2000) Urinary excretion of gluthatione S transferases alpha and pi in patients with proteinuria: reflection of the site of tubular injury. Nephron 85:120–126CrossRef Branten AJ, Mulder TP, Peters WH, Assmann KJ, Wetzels JF (2000) Urinary excretion of gluthatione S transferases alpha and pi in patients with proteinuria: reflection of the site of tubular injury. Nephron 85:120–126CrossRef
23.
go back to reference Rahn KH (1991) Acute disturbances of renal function. Chest 100 [Suppl]:197S–199S Rahn KH (1991) Acute disturbances of renal function. Chest 100 [Suppl]:197S–199S
24.
go back to reference Ascione R, Lloyd CT, Underwood MJ (1999) On-pump versus off-pump cronary revascularization: evaluation of renal function. Ann Thorac Surg 68:493–498CrossRef Ascione R, Lloyd CT, Underwood MJ (1999) On-pump versus off-pump cronary revascularization: evaluation of renal function. Ann Thorac Surg 68:493–498CrossRef
25.
go back to reference Moran M, Kapsner C (1987) Acute renal failure associated with elevated plasma oncotic pressure. N Engl J Med 317:150–153CrossRef Moran M, Kapsner C (1987) Acute renal failure associated with elevated plasma oncotic pressure. N Engl J Med 317:150–153CrossRef
26.
go back to reference Chinitz JL, Kim KE, Onesti G, Swartz C (1971) Pathophysiology and prevention of dextran-40-induced anuria. J Lab Clin Med 77:76–87PubMed Chinitz JL, Kim KE, Onesti G, Swartz C (1971) Pathophysiology and prevention of dextran-40-induced anuria. J Lab Clin Med 77:76–87PubMed
27.
go back to reference Legendre C, Thervet E, Page B, Percheron A, Noel LH, Kreis H (1993) Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet 342:248–249CrossRef Legendre C, Thervet E, Page B, Percheron A, Noel LH, Kreis H (1993) Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet 342:248–249CrossRef
28.
go back to reference Iana A, Schwartz D (1994) Renal tubular cellular and molecular events in acute renal failure. Nephron 68:413–418CrossRef Iana A, Schwartz D (1994) Renal tubular cellular and molecular events in acute renal failure. Nephron 68:413–418CrossRef
29.
go back to reference Jungheinrich C, Scharf R, Wargenau M, Bepperling F, Baron JF (2002) The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethylstarch 130/0.4 (6%, 500 ml) in mild-to-severe renal impairment. Anesth Analg 95:544–551PubMed Jungheinrich C, Scharf R, Wargenau M, Bepperling F, Baron JF (2002) The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethylstarch 130/0.4 (6%, 500 ml) in mild-to-severe renal impairment. Anesth Analg 95:544–551PubMed
Metadata
Title
RETRACTED ARTICLE: Influence of two different volume replacement regimens on renal function in elderly patients undergoing cardiac surgery: comparison of a new starch preparation with gelatin
Authors
Joachim Boldt
Thorsten Brenner
Andreas Lehmann
Johannes Lang
Bernhard Kumle
Christiane Werling
Publication date
01-05-2003
Publisher
Springer Berlin Heidelberg
Published in
Intensive Care Medicine / Issue 5/2003
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-003-1702-6

Other articles of this Issue 5/2003

Intensive Care Medicine 5/2003 Go to the issue

Physiological Note

Lactic acidosis

Announcements

May 2003